Approaches to Switching Between Antihistamines and Other Medications When Treating Patients with Chronic Spontaneous Urticaria 

EP: 1.The Pathophysiology of Chronic Spontaneous Urticaria

EP: 2.Hallmark Symptoms of Chronic Spontaneous Urticaria

EP: 3.The Epidemiology Associated With Chronic Spontaneous Urticaria 

EP: 4.Differential Diagnosis When Considering Chronic Spontaneous Urticaria 

EP: 5.Healthcare Specialties Involved in Managing Patients With Chronic Spontaneous Urticaria 

EP: 6.Therapies Typically Used in the Firstline For Patients With Chronic Spontaneous Urticaria 

Now Viewing

EP: 7.Approaches to Switching Between Antihistamines and Other Medications When Treating Patients with Chronic Spontaneous Urticaria 

EP: 8.The Use of Systemic Corticosteroids In Chronic Spontaneous Urticaria Treatment

EP: 9.Addressing Persistent Symptoms in Chronic Spontaneous Urticaria: Beyond IgE-Targeted Treatments

EP: 10.Key Updates Needed in Chronic Spontaneous Urticaria Guidelines

EP: 11.The Evaluation of Dupilumab In Chronic Spontaneous Urticaria Treatment

EP: 12.Navigating New Frontiers: Bruton Tyrosine Kinase Inhibitors in Chronic Spontaneous Urticaria Treatment

EP: 13.Patient Education, Provider Education, and Overall Final Thoughts

Video content above is prompted by the following question(s):

• A significant number of patients with CSU do not respond adequately to antihistamines. What is your approach to switching between (or adding on) antihistamines and when do you switch to another class of medications?
• How does antihistamine switching and treatment selection correlate with timing of disease episodes?
• If patients aren’t responding well to antihistamines, which therapies do you use next? When do you consider using biologics? What considerations do you take into account and what ultimately is driving that decision?